Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

National Stigma Survey About Mental Illness, Intellectual Disability and Homelessness in Spain

13 de diciembre de 2021 actualizado por: Universidad Complutense de Madrid

National Stigma Survey About Mental Illness, Homelessness and Intellectual Disability in Spain

This project is framed within the "Complutense University of Madrid (UCM)-Group 5 Against Stigma Chair", of the Faculty of Psychology. The main objective of the Chair is to fight the stigma that affects people with mental disorders, disabilities, vulnerability or extreme social exclusion. For this purpose, the Chair is developing research studies, training programs, cultural activities and awareness campaigns, proof of this is the recent publication of the Guide to good practices against stigma, which, although it takes as a reference to the people with a diagnosis of mental disorder, it is expected to be generalizable to other groups.

Stigma is associated with the condition of being different, and affects any person belonging to a minority or vulnerable group, being one of the main obstacles to full participation in different social, political and cultural institutions. The fight against stigma is included in important international treaties, such as the United Nations Convention on the Rights of Persons with Disabilities or the European recommendations regarding the fight against social exclusion of people with mental health problems.

This study will focus on three groups of special social sensitivity, with clear stigmatizing conditions: people with mental health problems, people in a homeless situation and people with intellectual disabilities.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Descripción detallada

The primary aim of this research is to describe the stigma faced by people corresponding to three highly vulnerable population groups: people with mental health problems, homeless people and people with intellectual disabilities.

From this general aim, four different specific goals are derived: 1) To delve into the experience of stigma of these groups, from first person; 2) To develop a quantitative assessment instrument that captures the current needs and experiences of people from these groups; 3) To describe and compare the social stigma of these three groups in a representative Spanish sample; 4) To address, from a gender perspective, possible differences in terms of the variables explored in the populations under study.

Tipo de estudio

De observación

Inscripción (Anticipado)

2750

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Manuel Muñoz, Ph.D.
  • Número de teléfono: 0034913943129
  • Correo electrónico: mmunozlo@ucm.es

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra de probabilidad

Población de estudio

An approximate sample size of 2750 interviews is estimated. The sample made up of the general population over 18 years of age obtained through the consumer panel methodology.

To obtain a representative sample of the Spanish population, quotas by sex and age group are included, as well as data for each of the 17 autonomous communities through simple affixing, ensuring a minimum of 100 surveys per Autonomous Community. On the other hand, it also allows a rural-urban analysis in the sample as a whole and in the most populated autonomous communities.

Descripción

Inclusion Criteria:

  • People aged 18 and over from general population.
  • Any gender.

Exclusion Criteria:

  • People under 18 years old.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Social distance desire
Periodo de tiempo: Up to 8 weeks
Reported and Intended Behaviour Scale (RIBS). The scale was adapted by asking about future intentions to live with, have friendships with or let children interact with people with mental health problems, homelessness or intellectual disabilities. Responses consisted of Likert-type items (1 strongly agree, 5 strongly disagree). Higher scores are indicative of better future behaviour.
Up to 8 weeks
Attitudes towards mental disorders
Periodo de tiempo: Up to 8 weeks
Attributional Questionnaire-9 (AQ-9). It is a reduced version of the Attribution Questionnaire-27, consisting of 9 items instead of 27. The questionnaire includes 9 items in Likert-type format with 9 response alternatives ranging from "1 = not at all" to "9 = very much".
Up to 8 weeks
Attitudes towards disability
Periodo de tiempo: Up to 8 weeks
Attitudes to Disability Scale (ADS): This scale is one of the most complete scales for assessing stigma towards intellectual disability. It was developed as part of an international World Health Organization study, in which Spain participated alongside other countries. The scale consists of 16 Likert-type items (1 = strongly agree and 5 = strongly disagree). These items are gathered in 4 subscales: Inclusion-exclusion, Discrimination, Gains and Hopes. It has adequate psychometric properties.
Up to 8 weeks
Attitudes towards homelessness
Periodo de tiempo: Up to 8 weeks
Survey attitudes towards Homeless People: This scale consists of 9 Likert-type items (1 = strongly agree and 6 = strongly disagree). It explores various attitudes towards homeless people (people sleeping on the streets or in shelters). It has good psychometric properties.
Up to 8 weeks
Disclosure about mental disorders
Periodo de tiempo: Up to 8 weeks
This scale assess opinions and attitudes towards disclosure of mental health problems, as well as the ability to talk about them and to identify the main agents and sources of support for people, through this question: "If a close person (family member, friend, partner) had a mental health problem...? ". Questions are rated on a 5 Likert-type scale, where 1 = I would definitely talk about it with them, and 5 = I would avoid talking about it with them.
Up to 8 weeks
Key aspects of stigma
Periodo de tiempo: Up to 8 weeks
In addition to the standardized instruments, a number of selected questions on key aspects of stigma are included in the survey. These qualitative aspects were highlighted by people with mental illness, people experiencing homelessness, and people with intellectual disabilities who participated in a series of focus groups. Questions are rated on a 5 Likert-type scale (1 = strongly disagree and 5 = strongly agree)
Up to 8 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Colaboradores

Investigadores

  • Silla de estudio: Manuel Muñoz, Ph.D., Universidad Complutense de Madrid
  • Investigador principal: Manuel Muñoz, Ph.D., Universidad Complutense de Madrid

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Anticipado)

1 de enero de 2022

Finalización primaria (Anticipado)

1 de febrero de 2022

Finalización del estudio (Anticipado)

1 de febrero de 2022

Fechas de registro del estudio

Enviado por primera vez

17 de noviembre de 2021

Primero enviado que cumplió con los criterios de control de calidad

13 de diciembre de 2021

Publicado por primera vez (Actual)

3 de enero de 2022

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

3 de enero de 2022

Última actualización enviada que cumplió con los criterios de control de calidad

13 de diciembre de 2021

Última verificación

1 de octubre de 2021

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Población general

3
Suscribir